batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Dual-payload conjugates see CDK7 debut 25 September 2025 Immuneering makes the most of its pancreatic promise 25 September 2025 Bristol touts its first pivotal celmod win 24 September 2025 Roche looks earlier with divarasib 23 September 2025 US action on subcutaneous cancer drugs 22 September 2025 Kairos sets its prostate cancer expectations 22 September 2025 Replimune crashes after FDA meeting 22 September 2025 Hopes dim for Innate’s NK-cell engagers 17 September 2025 Load More